Colorectal Cancer
Innovative Cellular Therapeutics' CAR-T Shows Early Activity, Safety in Colorectal Cancer
The company is hoping to advance a registrational trial for the CoupledCAR therapy GCC19CART based on data from a dose-escalation study ongoing in China.
Personalis, Ono Pharmaceutical, Japan National Cancer Center Partner on Opdivo Rectal Cancer Trial
In the multicenter VOLTAGE-2 trial, investigators will compare results of the company's tests with standard-of-care measures of drug response.
Sofie Biosciences Images First Gastrointestinal Cancer Patient in Phase II Radiopharmaceutical Trial
The firm is evaluating its fluorine-18 labeled PET imaging agent as a tool for identifying patients with FAP-expressing gastrointestinal cancers.
Researchers want drugmakers to clinically test a predictive model that early studies have shown can determine if a patient's tumor is truly dependent on the KRAS pathway.
Guardant Health Pushing Hard to Contextualize CRC Screening Data as Core Business Chugs Along
Premium
The company is seeing continuing growth for its existing clinical products as it moves resources toward commercialization of its Guardant Shield CRC screening test.